Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.69 USD | -4.86% | +1.18% | -2.49% |
04/06 | Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating | MT |
28/05 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.49% | 346.8Cr | |
+47.37% | 77TCr | |
-6.76% | 35TCr | |
+19.29% | 33TCr | |
+8.60% | 30TCr | |
+18.87% | 25TCr | |
-1.96% | 22TCr | |
+11.11% | 22TCr | |
+5.02% | 16TCr | |
-2.26% | 16TCr |
- Stock Market
- Equities
- CORT Stock
- News Corcept Therapeutics Incorporated
- William Guyer to Join Corcept as Chief Development Officer, Effective August 16, 2021